Editor’s note: A recording of the conversation is embedded below.
Every week, STAT+ subscribers get access to exclusive content with biotech, pharma, and health tech leaders. This week, STAT Pharmalot columnist and senior writer Ed Silverman will be joined by John Rex, editor-in-chief at AMR Solutions and chief medical officer at F2G Ltd. They will be discussing the revitalization of the antibiotic drug pipeline, drug development efforts, legislation and model programs to move the ball forward, and of course be taking your questions live.
About the Author Reprints
